A systematic CRISPR screen defines mutational mechanisms underpinning signatures caused by replication errors and endogenous DNA damage.

Saved in:
Bibliographic Details
Title: A systematic CRISPR screen defines mutational mechanisms underpinning signatures caused by replication errors and endogenous DNA damage.
Authors: Zou X; Academic Department of Medical Genetics, School of Clinical Medicine, University of Cambridge, Cambridge, UK.; MRC Cancer Unit, University of Cambridge, Cambridge, UK.; Wellcome Sanger Institute, Hinxton, UK., Koh GCC; Academic Department of Medical Genetics, School of Clinical Medicine, University of Cambridge, Cambridge, UK.; MRC Cancer Unit, University of Cambridge, Cambridge, UK.; Wellcome Sanger Institute, Hinxton, UK., Nanda AS; Academic Department of Medical Genetics, School of Clinical Medicine, University of Cambridge, Cambridge, UK.; MRC Cancer Unit, University of Cambridge, Cambridge, UK., Degasperi A; Academic Department of Medical Genetics, School of Clinical Medicine, University of Cambridge, Cambridge, UK.; MRC Cancer Unit, University of Cambridge, Cambridge, UK.; Wellcome Sanger Institute, Hinxton, UK., Urgo K; Wellcome Sanger Institute, Hinxton, UK., Roumeliotis TI; The Institute of Cancer Research, Chester Beatty Laboratories, London, UK., Agu CA; Wellcome Sanger Institute, Hinxton, UK., Badja C; Academic Department of Medical Genetics, School of Clinical Medicine, University of Cambridge, Cambridge, UK.; MRC Cancer Unit, University of Cambridge, Cambridge, UK.; Wellcome Sanger Institute, Hinxton, UK., Momen S; Academic Department of Medical Genetics, School of Clinical Medicine, University of Cambridge, Cambridge, UK.; MRC Cancer Unit, University of Cambridge, Cambridge, UK., Young J; Academic Department of Medical Genetics, School of Clinical Medicine, University of Cambridge, Cambridge, UK., Amarante TD; Academic Department of Medical Genetics, School of Clinical Medicine, University of Cambridge, Cambridge, UK.; MRC Cancer Unit, University of Cambridge, Cambridge, UK., Side L; UCL Institute for Women's Health, Great Ormond Street Hospital, London, UK.; Wessex Clinical Genetics Service, Princess Anne Hospital, Southampton, UK., Brice G; Southwest Thames Regional Genetics Service, St George's University of London, London, UK., Perez-Alonso V; Pediatrics Department, Doce de Octubre University Hospital, i+12 Research Institute, Madrid, Spain., Rueda D; Hereditary Cancer Laboratory, Doce de Octubre University Hospital, i+12 Research Institute, Madrid, Spain., Gomez C; Wellcome Sanger Institute, Hinxton, UK., Bushell W; Wellcome Sanger Institute, Hinxton, UK., Harris R; Academic Department of Medical Genetics, School of Clinical Medicine, University of Cambridge, Cambridge, UK.; Wellcome Sanger Institute, Hinxton, UK., Choudhary JS; The Institute of Cancer Research, Chester Beatty Laboratories, London, UK., Jiricny J; Institute of Molecular Life Sciences, University of Zurich, Zurich, Switzerland.; Institute of Biochemistry, ETH Zurich, Zurich, Switzerland., Skarnes WC; Wellcome Sanger Institute, Hinxton, UK.; William Harvey Research Institute, Queen Mary University of London, London, UK., Nik-Zainal S; Academic Department of Medical Genetics, School of Clinical Medicine, University of Cambridge, Cambridge, UK. snz@mrc-cu.cam.ac.uk.; MRC Cancer Unit, University of Cambridge, Cambridge, UK. snz@mrc-cu.cam.ac.uk.; Wellcome Sanger Institute, Hinxton, UK. snz@mrc-cu.cam.ac.uk.
Corporate Authors: Genomics England Research Consortium
Source: Nature cancer [Nat Cancer] 2021 Jun; Vol. 2 (6), pp. 643-657. Date of Electronic Publication: 2021 Apr 26.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101761119 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2662-1347 (Electronic) Linking ISSN: 26621347 NLM ISO Abbreviation: Nat Cancer
Database: MEDLINE Ultimate
Description
ISSN:2662-1347
DOI:10.1038/s43018-021-00200-0